Institute of Biomedical Sciences, Academia Sinica Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2009
NCT02065388
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Institute of Biomedical Sciences, Academia Sinica

Active Ingredients

Drugs in Phase 3 Trials (1)

warfarin (coumadin) (1 trial)

Drugs in Other Trials (3)

citric acid (1 trial)

magnesium citrate (1 trial)

sucralose (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 3)

Atrial Flutter (Phase 3)

Thrombosis (Phase 3)

Venous Thrombosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4